Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)

Clinical trial NCT07153445 · RECRUITING

Trial details

NCT number: NCT07153445
Sponsor: Fundación GECP
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Stage IIIA Lung Cancer Stage IIIB Lung Cancer

Start date: 2025-07-08
Primary completion: 2035-05-02
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.